Pular para o conteúdo principal
Ranking Invest

BDX - Becton, Dickinson and Company

Segmento: HealthcareBecton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Análise Ranking Invest

Valuation estimado
$ 27.90 Bi
Valor de Mercado
$ 48.44 Bi
Sobrepreço (AV)+73.6%
IVR
0.58A companhia vale 0,58 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.11O valuation alternativo equivale a 11% do valor de mercado da companhia.
MLL
0.11O lucro líquido dos controladores em 16 trimestres equivale a 11% do valor de mercado.
Último Balanço Atualizado: 3T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 24.42 Bi

Dívida Líquida

$ 16.10 Bi

L4T

$ 941.00 Mi

MM4T

4.15%

Indicadores Básicos

ROE

3.85%

Índices de Previsibilidade

Receita Líquida

B0.04

Lucro

B0.25

Margem

B0.24

Índices de Tendência

Receita Líquida

C6.19

Lucro

C2.01

Margem

D-0.18

Índices de Endividamento

DIV/PAT

0.66

DIV/L4T

17.11

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.